对比增强能谱乳腺X线摄影与三维乳腺超声对癌症患者病变范围特征评估的影响
该前瞻性分析纳入300个经病理证实为恶性的乳腺肿块,以手术数据为金标准,评估对比增强能谱乳腺X线摄影(CESM)与三维乳腺超声(3DUS)在表征乳腺内癌范围(主肿瘤大小、多发性、瘤周间质受累)中的作用。CESM与3DUS所测肿瘤大小与病理分析所测大小无显著差异;CESM在大小一致(5%范围内)的准确率(32.7%,n=98)高于3DUS(24.7%,n=74);CESM检测肿瘤多发性最准确(94%,n=282),传统超声乳腺X线摄影次之(88%,n=264),3DUS为84%(n=252);导管内延伸评估3DUS准确率98%(n=294),CESM仅60%(n=180)。结论认为CESM是推荐检查,可提高大小测量准确性和多发肿瘤检测,加用3DUS可增强导管内延伸检测。
要点
- CESM与3DUS所测肿瘤大小与病理所测无显著差异。
- CESM检测肿瘤多发性准确率94%(n=282),高于传统超声乳腺X线摄影88%(n=264)和3DUS 84%(n=252)。
- 3DUS评估导管内延伸准确率98%(n=294),高于CESM的60%(n=180)。
核心结论
- CESM是乳腺癌推荐检查,可提高大小测量准确性和多发肿瘤检测;加用3DUS可增强导管内延伸检测。
研究设计与样本
- 前瞻性分析,纳入300个经病理证实为恶性的乳腺肿块,以手术数据为金标准参考。
关键影像表现/征象
- CESM采用低能量(22-33 kVp)和高能量(44-49 kVp)曝光,在静脉注射对比剂后拍摄,随后行双侧3D乳腺超声。
- CESM与3DUS所测肿瘤大小与病理分析所测大小无显著差异。
- CESM检测肿瘤多发性准确率94%(n=282),传统超声乳腺X线摄影准确率88%(n=264),3D乳腺超声准确率84%(n=252)。
- 3D超声评估导管内延伸准确率98%(n=294),CESM准确率60%(n=180)。
诊断标准与关键数值
- CESM在大小一致(5%范围内)的准确率为32.7%(n=98),3D超声为24.7%(n=74)。
- CESM检测肿瘤多发性准确率94%(n=282),传统超声乳腺X线摄影88%(n=264),3D乳腺超声84%(n=252)。
- 3D超声评估导管内延伸准确率98%(n=294),CESM为60%(n=180)。
临床应用与阅片要点
- 作者认为CESM是乳腺癌推荐检查,可提高大小测量准确性和多发肿瘤检测。
- 作者认为加用3D超声可增强导管内延伸检测。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: The main importance of imaging breast cancer is to guide conservative surgeries. In this study, we evaluated the role of contrast-enhanced spectral mammogram (CESM) in correlation with three-dimensional (3D) breast ultrasound in characterizing the extension of the intramammary cancer in view of the: (i) the size of the main tumor, (ii) the multiplicity of the breast cancer, and (iii) the peri-tumoral stromal involvement (i.e. free or intraductal extension of the cancer).
METHODS: The study is a prospective analysis that included 300 breast masses proved to be malignant. The masses were evaluated for their size, multiplicity and surrounding stromal involvement. Contrast-based mammography performed with low (22-33 kVp) and high (44-49 kVp) energy exposures that were taken after i.v. injection of contrast agent and followed by bilateral 3D breast ultrasound. Operative data were the gold standard reference.
RESULTS: There was no significant difference between the sizes of the included cancers as measured by CESM and 3D ultrasound and that measured at the pathological analysis. CESM showed higher accuracy (32.7%, n = 98) than 3D ultrasound (24.7%, n = 74) in the size agreement within 5% range. CESM was the most accurate modality (94%, n = 282) in detecting tumor multiplicity, followed by traditional sonomammogram (88%, n = 264), then 3D breast ultrasound (84%, n = 252). Intraductal extension of the breast cancer was best evaluated by the 3D ultrasound with an accuracy value of 98% (n = 294) compared to only 60% (n = 180) by CESM.
CONCLUSION: CESM is a recommended investigation in breast cancer to increase the accuracy of size measurement and the detection of multiple tumors. The addition of 3D ultrasound can enhance the detection of intraductal extension. Advances in knowledge: Choice of conservative breast surgery vs mastectomy is still a debate. We used an advanced, contrast-based, application of the mammogram: CESM and a non-invasive 3D breast ultrasound in the assessment of the local extension of the breast cancer regarding size, perifocal stromal infiltration and multiplicity to guide the selection of proper management in proved cases of breast cancer.
引用
- Helal MH, Mansour SM, Salaleldin LA, et al. The impact of contrast-enhanced spectral mammogram (CESM) and three-dimensional breast ultrasound (3DUS) on the characterization of the disease extend in cancer patients. Br J Radiol. 2018. PMID: 29641226. doi:10.1259/bjr.20170977
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。